Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF-alpha Expression in Macrophages
Approved indications for GLP-1 drugs The U.S
Danish drugmaker Novo Nordisk outlined over $25 billion in world wide sales in 2024 off their popular semaglutide GLP-1 obesity medication
Administer once a day within the hour prior to the first meal of the day Efficacy Parkinson's disease Generic / Price NO/$$$$ Storage Unopened / Unused pens Store in refrigerator Good until expiration date on product After first use Store at room temperature Good for 28 days Xultophy Insulin degludec + liraglutide Insulin degludec + liraglutide Dosage forms Pen (100/3.6) 100 units/ml insulin degludec and 3.6 mg/ml liraglutide Pens contain 3 ml Comes in package of 5 pens Pen window shows units of insulin degludec Compatible with NovoFine and NovoTwist needles Dosing Type 2 diabetes Insulin degludec is a long-acting insulin, and liraglutide is a GLP-1 analog Pen is dialed to units of insulin degludec
